عنوان

Anticoagulants, antiplatelets, and thrombolytics /

1607618036

9781607618034

1607618028

9781607618027

b755039

Anticoagulants, antiplatelets, and thrombolytics /

[Book]

edited by Shaker A. Mousa.

2nd ed.

New York, N.Y. :

Humana Press,

©2010.

1 online resource (xi, 316 pages) :

illustrations

Methods in molecular biology,

Springer Protocols

663

1940-6029 ;

Includes bibliographical references and index.

In vitro methods of evaluating antithrombotics and thrombolytics / S.A. Mousa -- In vivo models for the evaluation of antithrombotics and thrombolytics / S.A. Mousa -- Heparin and low-molecular weight heparins in thrombosis and beyond / S.A. Mousa -- Laboratory methods and management of patients with heparin-induced thrombocytopenia / M. Prechel, W.P. Jeske and J.M. Walenga -- Novel anticoagulant therapy: Principle and practice / S.A. Mousa -- Oral direct factor xa inhibitors, with special emphasis on rivaroxaban / S.A. Mousa -- Antiplatelet therapies: Drug interactions in the management of vascular disorders / S.A. Mousa -- Prasugrel: A novel platelet adp p2y(12) receptor antagonist / S.A. Mousa, W.P. Jeske and J. Fareed -- Antithrombotic effects of naturally derived products on coagulation and platelet function / S.A. Mousa -- Assessment of anti-metastatic effects of anticoagulant and antiplatelet agents using animal models of experimental lung metastasis / A. Amirkhosravi [and others] -- Adhesion molecules: Potential therapeutic and diagnostic implications / S.A. Mousa -- Pharmacogenomics in thrombosis / S.A. Mousa -- Diagnosis and management of sickle cell disorders / S.A. Mousa and M.H. Qari.

0

During the past decade, remarkable progress has been made in the development of newer drugs to prevent and treat thromboembolic disorders, such as oral direct anti-Xa and anti-IIa antagonists, as well as oral antiplatelet ADP antagonists with rapid onset and offset. In addition, there has been concentrated effort aimed at identifying novel uses of traditional antithrombotic drugs, such as aspirin, heparin, and oral anticoagulants, as well as combinations of agents, such as more than one antiplatelet, antiplatelet with anticoagulant, antiplatelet with or without thrombolytic. Anticoagulants, Antiplatelets, and Thrombolytics, Second Edition provides updates on various strategies in thrombosis, experimental models, and clinical and recent advances in the discovery and development of novel antithrombotics. As a volume in the highly successful Methods in Molecular Biology series, this collection provides the kind of detailed description and implementation advice that is crucial for getting optimal results. Easy to use and up to date, Anticoagulants, Antiplatelets, and Thrombolytics, Second Edition is an ideal guide for researchers aiming for the future of this vital field, focusing on the prevention of thromboembolic disorders and the protection of the vascular endothelium.

Springer

978-1-60761-802-7

Anticoagulants, antiplatelets, and thrombolytics.

9781607618027

Anticoagulants (Medicine)

Blood platelets.

Fibrinolytic agents.

Thrombolytic therapy.

Analytical, Diagnostic and Therapeutic Techniques and Equipment

Anticoagulants.

Blood Platelet Disorders.

Carbohydrates.

Cardiovascular Agents.

Chemical Actions and Uses

Chemicals and Drugs

Disease.

Drug Therapy.

Fibrin Modulating Agents.

Fibrinolytic Agents.

Glycosaminoglycans.

Hematologic Agents.

Hematologic Diseases.

Hemic and Lymphatic Diseases

Heparin.

Investigative Techniques

Methods.

Molecular Mechanisms of Pharmacological Action

Pharmacologic Actions

Platelet Aggregation Inhibitors.

Polysaccharides.

Therapeutic Uses

Therapeutics.

Thrombocytopenia.

Thrombolytic Therapy.

Anticoagulants (Medicine)

Blood platelets.

Fibrinolytic agents.

Thrombolytic therapy.

MBGR

MED067000

PSD

SCI049000

Mousa, Shaker A.

20201204150133.0

pn

[Book]

Y